Drugdiscovery >> Upcoming Events >> News
2228
Views
GRASPA-ML of Eryech is in  Phase IIb - drugdiscovery.com
GRASPA-ML of Eryech is in Phase IIb - drugdiscovery.com


Erytech is a pharmaceutical company which specialized itself on the research of leukemia and other onclogy illnesses. The companí announced that its new durg, GRASPA-ML was authorized in Phase IIb trial in Finland and Spain.
Read More >>


Tags: Finland, Spain, GRASPA-ML, Erytech, leukemia - January 15, 2014
Related Articles
No Related Articles
MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013